Top Sell
| Security | Buy | Sell | Buy (1M) | Sell (1M) | Price | Target price | Potential |
|---|---|---|---|---|---|---|---|
| Novan Inc | 0 | 23 | 0 | 2 | €0.001 | - | - |
| Evoke Pharma Inc. | 0 | 22 | 0 | 1 | €0.47 | - | - |
| Moleculin Biotech Inc | 4 | 26 | 2 | 1 | €0.41 | €16.50 | 3923.805% |
| AEterna Zentaris Inc. | 3 | 20 | 1 | 3 | €1.85 | €14.02 | 657.865% |
| Bellicum Pharmaceuticals Inc. | 0 | 15 | 0 | 2 | €0.064 | - | - |
| Neptune Wellness Solutions Inc | 0 | 15 | 0 | 2 | €0.14 | - | - |
| Tonix Pharmaceuticals Holding Corp. | 2 | 15 | 0 | 0 | €2.82 | €5.03 | 78.387% |
| Cyclacel Pharmaceuticals Inc. | 1 | 14 | 0 | 0 | €0.22 | €19.12 | 8591.136% |
| Trevena Inc. | 1 | 14 | 1 | 3 | €0.44 | €8.37 | 1794.994% |
| CEL-SCI Corp. | 0 | 6 | 0 | 0 | €1.42 | - | - |
| Organovo Holdings Inc. | 0 | 5 | 0 | 1 | €1.10 | €3.00 | 172.727% |
| Palatin Technologies Inc. | 0 | 4 | 0 | 1 | €1.74 | - | - |
| Nymox Pharmaceutical Corp. | 0 | 4 | 0 | 0 | €0.23 | - | - |
| Minerva Neurosciences Inc. | 1 | 5 | 0 | 1 | €2.32 | €7.00 | 201.724% |
| Fibrogen Inc. | 1 | 4 | 0 | 1 | €1.02 | €0.000 | -100.000% |
| Medigene AG | 0 | 2 | 0 | 1 | €1.91 | €1.00 | -47.507% |
| iBio Inc. | 0 | 2 | 0 | 1 | €0.18 | €0.20 | 9.290% |
| Larimar Therapeutics Inc. | 2 | 4 | 0 | 0 | €5.85 | €7.00 | 19.658% |
| Bluebird Bio Inc. | 4 | 6 | 0 | 2 | €0.90 | €6.49 | 621.413% |
| BioLine RX Ltd ADR | 0 | 2 | 0 | 1 | €0.66 | - | - |
| Biofrontera AG | 0 | 2 | 0 | 1 | €0.30 | €0.000 | -100.000% |
| Anavex Life Sciences Corp | 0 | 2 | 0 | 1 | €3.46 | - | - |
| CytoTools AG | 0 | 1 | 0 | 0 | €0.55 | - | - |
| Sangamo Therapeutics Inc. | 11 | 12 | 1 | 1 | €0.49 | €2.79 | 473.932% |
| Takara Bio Inc. | 0 | 1 | 0 | 1 | €5.55 | - | - |